Tasigna (nilotinib), among the most popular cancer drugs in the world, has been found to cause rapid, severe and irreversible atherosclerosis, a condition which can result in limb amputation, peripheral arterial disease and cardiovascular problems, and death. Used to treat Philadelphia chromosome-positive chronic myeloid leukemia, Tasigna was linked to atherosclerosis in 2011, yet the American public was not warned of the risk. Through no fault of their own, thousands of Delaware residents have taken Tasigna, in hopes it would improve their health and completely unaware of the danger of Tasigna atherosclerosis.
Tasigna is manufactured and marketed by the billion dollar pharmaceutical corporation Novartis. Based in Switzerland, Novartis settled a 2013 lawsuit by paying $390 million to the U.S. Department of Justice concerning the payment of illegal kickbacks, misbranding and the use of false advertising claims concerning Tasigna. Novartis has been aware of the Tasigna atherosclerosis risk since 2011, yet purposefully concealed the information from American doctors and patients. By 2013, Novartis had publicly admitted the Tasigna atherosclerosis in Canada, where it issued a Tasigna side effects warning in conjunction with Health Canada; no such warning was issued in the United States. Used to treat chronic myloid leukemia, Tasigna is ranked among the ten most popular cancer drugs in the world; global sales of Tasigna exceeded $1.7 billion in 2016.
If you or a family member in Delaware was harmed by Tasigna atherosclerosis, you may be eligible to receive compensation through filing a Delaware Tasigna lawsuit. Backed by a strong track record in holding pharmaceutical giants accountable for the harm caused by dangerous drugs, Onder Law lawerys handling Delaware Tasigna cases will work tirelessly on your behalf to pursue justice. Contact the firm today for a free, no-obligation Delaware Tasigna atherosclerosis case evaluation. Should you choose to retain our Delaware Tasigna attorneys, there is never any fee unless we win compensation on your behalf.
If you or a member of your family in Delaware suffered from Tasigna side effects including atherosclerosis, peripheral arterial disease, tissue death requiring amputation, or other cardiovascular problems, you may have legal grounds to file a Delaware Tasigna lawsuit against Novartis. Delaware Tasigna atherosclerosis lawsuits enable individuals to seek compensation for the medical expenses, pain and suffering that have resulted from this dangerous drug.
Tasigna is among the most popular cancer drugs prescribed around the world. Many patients in Delaware took Tasigna completely unaware of the life-threatening risks it posed. Only now, after many patients have stepped forward to report severe Tasigna complications, are Americans learning about the risk. Our attorneys believe that persons in Delaware who were harmed by Tasigna side effects through no fault of their own deserve compensation for their losses and suffering.
Researchers first discovered the link between Tasigna and atherosclerosis in 2011, and many peer-reviewed studies have confirmed the finding. The risk for severe and life-threatening Tasigna side effects was never brought to the attention of doctors or patients; instead, Novartis engaged in aggressive and sometimes illegal marketing tactics to drive Tasigna to become one of the ten-most popular cancer drugs in the world. Tasigna garnered more than $1.7 billion in sales during 2016, putting millions of patients at risk. Patients taking Tasigna were not adequately warned about the risk for atherosclerosis or resultant peripheral arterial disease.
Filing a lawsuit is often the only means an individual consumer has to hold a large multi-national corporation accountable for consumer safety. For persons and the family members of persons in Delaware who have suffered from Tasigna atherosclerosis and resulting complications such as peripheral arterial disease, limb amputation, and other cardiovascular problems may qualify to file a Delaware Tasigna lawsuit to recover compensation for damages suffered.
Unfortunately, facing the threat of major litigation is often the only factor that effectively motivates a company to increase its attention toward consumer safety. Motivated by profits, short cuts in premarket testing and negligence toward safety become commonplace. To some extent, litigation is seen as a cost of doing business to these large corporations, and harming some patients along the way seems inevitable. Filing a Delaware Tasigna lawsuit can help individuals recover the compensation they deserve, and also serves to hold Novartis accountable for the safety of its pharmaceutical drugs in the long run.
Our attorneys provide free Tasigna lawsuit case review with no further obligation to any person who has been harmed by Tasigna in Delaware and throughout the United States. Use this site's contact form or live chat feature to contact an lawyer handling Delaware Tasigna claims. You will be contacted promptly for a free case evaluation with an experienced products liability attorney. We will be happy to discuss your circumstances in detail and answer your questions as definitively as possible.
Tasigna lawsuits for Delaware residents will not be class action lawsuits in which those who file a claim can expect only a small, symbolic settlement. Our lawyers handling Delaware Tasigna claims believe persons and family members of persons who have suffered from atherosclerosis, peripheral arterial disease, amputation, or other severe Tasigna side effects in Delaware deserve significant compensation. While Delaware Tasigna claims will likely be consolidated with others from around the nation as a Federal Multi-District Litigation (MDL), each claim will be handled on its own merit and compensation will be determined based on the degree of suffering of each plaintiff. A Tasigna lawsuit MDL would consolidate similar cases nationwide against Novartis, while still preserving the unique details of each Delaware Tasigna lawsuit.
We will represent all Delaware residents involved in a Federal court Tasigna lawsuit for atherosclerosis, peripheral arterial disease, amputation, and cardiovascular complications on a contingency basis, meaning our attorneys charge never charge any legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form and one of our Tasigna lawyers handling Delaware will contact you to answer any of your questions.
This page provides answers to common Tasigna lawsuit questions that apply to most atherosclerosis claims from Delaware. For answers to more specific questions, contact our firm. Our team of attorneys handling Tasigna lawsuit claims for Delaware provides free, no obligation Tasigna lawsuit case review and will be happy to discuss your case in detail. One of our experienced lawyers handling Tasigna lawsuit claims for Delaware will contact you to answer your questions, completely free of charge.
Any person or family member of a person who took Tasigna and developed atherosclerosis or peripheral arterial disease, required amputation, or suffered from another Tasigna problem in Delaware may be eligible to make a claim by filing a Delaware Tasigna lawsuit against Novartis.
We will always listen to your circumstances and give you our analysis of your case without any cost or further obligation.
Novartis officials have known about Tasigna atherosclerosis and related health risks since 2011, when the first study on the subject was published in the American Journal of Hematology. Many more related studies were published in prominent, peer-reviewed jounrals in the United States, Canada and Europe in the ensuing years. The pressing question is why did Novartis officials wait so long to warn Americans? (The Canadian public was warned in 2013.) Tasigna lawsuits against Novartis aim to hold the company accountable for prioritizing company profits over consumer safety.
We are committed to representing all Delaware residents involved in a Tasigna lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. To access your free, no-obligation consultation, use the online chat feature or contact form on this site. One of our lawyers handling Tasigna lawsuits for Delaware will contact you to answer any of your questions.
Any person who was prescribed Tasigna for chronic myeloid leukemia (or for another condition) may suffer from atherosclerosis, peripheral arterial disease, and corresponding Tasigna complications. Even persons who have no prior history with cardiovascular problems may develop severe Tasigna side effects. Tasigna complications often have a rapid onset and may be life-threatening.
In most cases, no. These cases are generally not filed in Delaware, but instead through the Federal Courts. Because of the likelihood that Tasigna peripheral arterial disease lawsuits will be consolidated into a Multi-District Litigation (MDL) in a federal court where one or more of the initial Tasigna peripheral arterial disease lawsuits has been filed. Most people with a claim from Delaware will be better off with a firm that has medical device MDL experience and the resources to battle a multi-billion dollar, multi-national conglomerate. Onder Law has a history of doing just that. Additionally, we have strong relationships with other law firms and attorneys throughout the country and never hesitate to enlist the services of other attorneys when it is in the best interests of our clients.
The majority of our drug cases are handled as a MDL, or Multi-District Litigation, where each plaintiff receives a settlement based upon the individual injuries and damages incurred by each plaintiff. In most Multi-District Litigation for pharmaceuticals and medical devices, plaintiff settlement amounts average between tens and hundreds of thousands of dollars.
If a member of your family suffered a serious injury or health problem as a result of a defective product or dangerous drug, long-term, or even life-long, medical care may be required. This could be incredibly expensive and since medical costs are continually rising may be largely unknown at the time of settlement or trial. If a member of your family died due to a defective product or dangerous drug, no amount of money can undo that wrong. It is our fervent hope that every defective products, drug or other medication lawsuit we file can serve to make the manufacturer take note of the loss and pain its product has caused. When that fails to make a company take action in the form of a product recall, greater warnings about its use and ultimately making safer products, we rely on their profit motivation to make them do the right thing. Unfortunately, in all too many cases it is only the fear of lawsuits and large settlements and verdicts that makes a company become a better corporate citizen.
Most states have Tasigna lawsuit time limits; however, the majority of all persons having taken Tasigna will fall within those time limits if they contact an attorney in the near future. For specific time limits for applicable to your case, please fill out the form at right and one of our attorneys will contact you as quickly as possible, usually within the hour.
The Delaware Tasigna attorneys at OnderLaw, LLC, have a long track record of success in achieving justice on behalf of American families harmed by billion-dollar, multinational drug companies. When a pharmaceutical company blatantly prioritizes profits over consumer safety, our firm is committed to working tirelessly to seeking justice on behalf of consumers. In this case, Novartis purposefully concealed Tasigna risk information from the American public, while simultaneously engaging in aggressive and unethical advertising and payment of illegal kickbacks to promote the drug. Our Tasigna lawyers believe persons and family members of persons who were harmed by Tasigna side effects in Delaware may be eligible for real compensation by filing a claim against Novartis.
Our experienced Tasigna lawyers have seen the aftereffects of numerous drug recalls. Cognizant of the very serious nature of Delaware Tasigna atherosclerosis injuries, our national drug litigation law firm is offering its significant resources to provide clients in Delaware with the best Tasigna attorney representation. Our Delaware Tasigna claim lawyers will provide a free case review to persons and family members of persons who have been harmed by Tasigna. Unlike consumers in Canada, American patients were never warned of the risk of peripheral arterial disease from Tasigna, and were exposed to a life-threating risk without their knowledge and have suffered through no fault of their own. Our Tasigna lawyers aim to achieve compensation for Delaware residents for loss and suffering, while holding Novartis accountable for its actions.
When a pharmaceutical company blatantly prioritizes profits over consumer safety, our firm is committed to working tirelessly to seeking justice on behalf of consumers.
If you or someone you love has been harmed by Tasigna in Delaware, you may be eligible for significant compensation through filing a claim. Contact our firm to access your free, no-obligation case review with an experienced Delaware Tasigna atherosclerosis lawyer.
Tasigna was first approved in the United States in 2007 as a treatment for chronic myeloid leukemia. Over the years, Tasigna has risen to prominence as one of the ten most popular drugs used to treat cancer worldwide. Tasigna has been found to cause atherosclerosis and related health problems in patients, including peripheral arterial disease, tissue death and amputation, and cardiovascular complications. Consumers in other countries have been adequately warned of the risks of taking Tasigna. Our Delaware Tasigna attorneys believe Novartis must be held accountable for its disregard of consumer safety in this country.
Working on behalf of individuals who have suffered limb amputation, atherosclerosis, or peripheral arterial disease, our Tasigna attorneys will work tirelessly for justice no matter how complex the case. Tasigna lawsuits endeavor to win real compensation for the pain, suffering, medical expenses and lost income resulting from Tasigna complications.
We will represent all persons involved in Delaware Tasigna claims on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who took Tasigna and suffered severe side effects in Delaware or is a family member of such a person is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Delaware Tasigna attorneys will contact you promptly to discuss your case.
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro, Talcum Powder and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal, Testosterone and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.OnderLaw.com or call 1-877-ONDER-LAW.